Alex Virgo

Advised a research-based biopharmaceutical company on specific compliance with State and Commonwealth legislation, such as the Health Practitioner Regulation National Laws, Health Insurance Act, Private Health Insurance Act and State-based health legislation.

Advising Catalent Pharma Solutions, Inc., a global listed pharmaceutical company headquartered in the U.S., in relation to the sale of 100% of its tablet and soft-gel capsule manufacturing facility in Victoria, Australia for AUD43.2 million to Blackmores Limited.

Advising clients on compliance with regulations relating to the advertisement of health services with a particular focus on compliance with the uniform Health Practitioner Regulation National Laws and the Australian Health Practitioner Regulation Agency codes of conduct.

Advising an U.S. based manufacturer of industrial products in relation to its obligations under the Modern Slavery Act 2018 (Cth).

Advising clients operating in the aged care industry in relation to their preparation for the Royal Commission into Aged Care Quality and Safety.

Advising a number of private health insurers on private health insurance and health regulation, advertising and privacy.

Providing privacy advice to clients in the health industry.

Advising a number of organisations on various aspects of their health practices, including the acquisition and sale of various medical practices and aged care/retirement living facilities and structuring, due diligence and advising on regulatory issues relevant to the same.